A meta-analysis of the association of N-acetyltransferase 2 gene (NAT2) variants with breast cancer

American Journal of Epidemiology

Volumn 166, Issue 3, 2007, Pages 246-254

  Ochs Balcom, Heather M ^a,b   Wiesner, Georgia ^b,c   Elston, Robert C ^a,b,c  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acetyltransferases; Breast neoplasms; Epidemiology; Genotype; Meat; NAT2; Polymorphism, genetic

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,6 B]PYRIDINE; AROMATIC AMINE; ARYLAMINE ACETYLTRANSFERASE; HETEROCYCLIC AMINE; PYRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

CANCER; CARCINOGEN; ENZYME ACTIVITY; GENE EXPRESSION; GENOTYPE; HEALTH RISK; MEAT; META-ANALYSIS; METABOLISM; ORGANIC NITROGEN COMPOUND; POLYMORPHISM; SMOKING;

ACETYLATION; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CLINICAL TRIAL; DETOXIFICATION; DISEASE ASSOCIATION; ENZYME ACTIVATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; LIFESTYLE MODIFICATION; MEAT; META ANALYSIS; METABOLISM; MOLECULAR INTERACTION; PHENOTYPE; REVIEW; RISK FACTOR; SMOKING; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW;

ARYLAMINE N-ACETYLTRANSFERASE; BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; ODDS RATIO; PHENOTYPE; SMOKING; VARIATION (GENETICS);

EID: 34547664620     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwm066     Document Type: Review

References (55)

1. Smith CA, Smith G, Wolf CR. Genetic polymorphisms in xenobiotic metabolism. Eur J Cancer 1994;30A:1921-35.
2. Hein DW. Acetylator genotype and arylamine-induced carcinogenesis. Biochim Biophys Acta 1988;948:37-66.
3. Brockton N, Little J, Sharp L, et al. N-acetyltransferase polymorphisms and colorectal cancer: a HuGE review. Am J Epidemiol 2000;151:846-61.
4. Marcus PM, Hayes RB, Vineis P, et al. Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction. Cancer Epidemiol Biomarkers Prev 2000;9:461-7.
5. Marcus PM, Vineis P, Rothman N. NAT2 slow acetylation and bladder cancer risk: a meta-analysis of 22 case-control studies conducted in the general population. Pharmacogenetics 2000;10:115-22.
6. Hein DW, Doll MA, Fretland AJ, et al. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev 2000;9:29-42.
7. Weber W. The acetylator genes and drug response. New York, NY: Oxford University Press, 1987.
8. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
9. Number Cruncher Statistical Systems. Kaysville, UT. (www.ncss.com).
10. Bulovskaya LN, Krupkin RG, Bochina TA, et al. Acetylator phenotype in patients with breast cancer. Oncology 1978;35:185-8.
11. Cartwright RA. Epidemiological studies on N-acetylation and C-center ring oxidation in neoplasia. Banbury report 16: Genetic variability in responses to chemical exposure. New York, NY: Cold Spring Harbor Laboratory, 1984.
12. Ilett KF, Detchon P, Ingram DM, et al. Acetylation phenotype is not associated with breast cancer. Cancer Res 1990;50:6649-51.
13. Ladero JM, Fernandez MJ, Palmeiro R, et al. Hepatic acetylator polymorphism in breast cancer patients. Oncology 1987;44:341-4.
14. Philip PA, Rogers HJ, Millis RR, et al. Acetylator status and its relationship to breast cancer and other diseases of the breast. Eur J Cancer Clin Oncol 1987;23:1701-6.
15. Sardas S, Cok I, Sardas OS, et al. Polymorphic N-acetylation capacity in breast cancer patients. Int J Cancer 1990;46:1138-9.
16. Webster DJ, Flook D, Jenkins J, et al. Drug acetylation in breast cancer. Br J Cancer 1989;60:236-7.
17. Deitz AC, Zheng W, Leff MA, et al. N-Acetyltransferase-2 (NAT2) acetylation polymorphism, well-done meat intake and breast cancer risk among post-menopausal women. (Abstract). Proc Am Assoc Cancer Res 1999;40:148.
18. Ambrosone CB, Freudenheim JL, Marshall JR, et al. The association of polymorphic N-acetyltransferase (NAT2) with breast cancer risk. Ann N Y Acad Sci 1995;768:250-2.
19. Chern HD, Huang CS, Wang CY, et al. Association of N-acetyltransferase polymorphism with the susceptibility of breast cancer in Taiwan. (Abstract). Proc Am Assoc Cancer Res 1997;38:214.
20. Lilla C, Risch A, Kropp S, et al. SULT1A1 genotype, active and passive smoking, and breast cancer risk by age 50 years in a German case-control study. Breast Cancer Res 2005;7:R229-37.
21. van der Hel OL, Bueno-de-Mesquita HB, van Gils CH, et al. Cumulative genetic defects in carcinogen metabolism may increase breast cancer risk (The Netherlands). Cancer Causes Control 2005;16:675-81.
22. Agundez JA, Ladero JM, Olivera M, et al. Genetic analysis of the arylamine N-acetyltransferase polymorphism in breast cancer patients. Oncology 1995;52:7-11.
23. Alberg AJ, Daudt A, Huang HY, et al. N-acetyltransferase 2 (NAT2) genotypes, cigarette smoking, and the risk of breast cancer. Cancer Detect Prev 2004;28:187-93.
24. Ambrosone CB, Freudenheim JL, Graham S, et al. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. JAMA 1996;276:1494-501.
25. Chang-Claude J, Kropp S, Jager B, et al. Differential effect of NAT2 on the association between active and passive smoke exposure and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:698-704.
26. Deitz AC, Zheng W, Leff MA, et al. N-Acetyltransferase-2 genetic polymorphism, well-done meat intake, and breast cancer risk among postmenopausal women. Cancer Epidemiol Biomarkers Prev 2000;9:905-10.
27. Delfino RJ, Smith C, West JG, et al. Breast cancer, passive and active cigarette smoking and N-acetyltransferase 2 genotype. Pharmacogenetics 2000;10:461-9.
28. Egan KM, Newcomb PA, Titus-Ernstoff L, et al. Association of NAT2 and smoking in relation to breast cancer incidence in a population-based case-control study (United States). Cancer Causes Control 2003;14:43-51.
29. Huang CS, Chern HD, Shen CY, et al. Association between N-acetyltransferase 2 (NAT2) genetic polymorphism and development of breast cancer in post-menopausal Chinese women in Taiwan, an area of great increase in breast cancer incidence. Int J Cancer 1999;82:175-9.
30. Hunter DJ, Hankinson SE, Hough H, et al. A prospective study of NAT2 acetylation genotype, cigarette smoking, and risk of breast cancer. Carcinogenesis 1997;18:2127-32.
31. Kocabas NA, Sardas S, Cholerton S, et al. N-acetyltransferase (NAT2) polymorphism and breast cancer susceptibility: a lack of association in a case-control study of Turkish population. Int J Toxicol 2004;23:25-31.
32. Krajinovic M, Ghadirian P, Richer C, et al. Genetic susceptibility to breast cancer in French-Canadians: role of carcinogen-metabolizing enzymes and gene-environment interactions. Int J Cancer 2001;92:220-5.
33. Lee KM, Park SK, Kim SU, et al. N-acetyltransferase (NAT1, NAT2) and glutathione S-transferase (GSTM1, GSTT1) polymorphisms in breast cancer. Cancer Lett 2003;196:179-86.
34. Matheson MC, Stevenson T, Akbarzadeh S, et al. GSTT1 null genotype increases risk of premenopausal breast cancer. Cancer Lett 2002;181:73-9.
35. Millikan RC, Pittman GS, Newman B, et al. Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 1998;7:371-8.
36. Morabia A, Bernstein MS, Bouchardy I, et al. Breast cancer and active and passive smoking: the role of the N-acetyltransferase 2 genotype. Am J Epidemiol 2000;152:226-32.
37. Sillanpaa P, Hirvonen A, Kataja V, et al. NAT2 slow acetylator genotype as an important modifier of breast cancer risk. Int J Cancer 2005;114:579-84.
38. van der Hel OL, Peeters PH, Hein DW, et al. NAT2 slow acetylation and GSTM1 null genotypes may increase postmenopausal breast cancer risk in long-term smoking women. Pharmacogenetics 2003;13:399-407.
39. Wu FY, Lee YJ, Chen DR, et al. Association of DNA-protein crosslinks and breast cancer. Mutat Res 2002;501:69-78.
40. Lissowska J, Brinton LA, Zatonski W, et al. Tobacco smoking, NAT2 acetylation genotype and breast cancer risk. Int J Cancer 2006;119:1961-9.
41. Bell DA, Taylor JA, Butler MA, et al. Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. Carcinogenesis 1993;14:1689-92.
42. Lin HJ, Han CY, Lin BK, et al. Slow acetylator mutations in the human polymorphic N-acetyltransferase gene in 786 Asians, blacks, Hispanics, and whites: application to metabolic epidemiology. Am J Hum Genet 1993;52:827-34.
43. Boyd NF, Stone J, Vogt KN, et al. Dietary fat and breast cancer risk revisited: a meta-analysis of the published literature. Br J Cancer 2003;89:1672-85.
44. Ambrosone CB, Freudenheim JL, Sinha R, et al. Breast cancer risk, meat consumption and N-acetyltransferase (NAT2) genetic polymorphisms. Int J Cancer 1998;75:825-30.
45. Gertig DM, Hankinson SE, Hough H, et al. N-acetyl transferase 2 genotypes, meat intake and breast cancer risk. Int J Cancer 1999;80:13-17.
46. Delfino RJ, Sinha R, Smith C, et al. Breast cancer, heterocyclic aromatic amines from meat and N-acetyltransferase 2 genotype. Carcinogenesis 2000;21:607-15.
47. Evans D. Acetylation. In: Kalow W, Goedde H, Agarwal D, eds. Ethnic differences in reactions to drugs and xenobiotics. New York, NY: Alan R Liss, Inc, 1986.
48. Pfau W, Stone EM, Brockstedt U, et al. DNA adducts in human breast tissue: association with N-acetyltransferase-2 (NAT2) and NAT1 genotypes. Cancer Epidemiol Biomarkers Prev 1998;7:1019-25.
49. Terry PD, Goodman M. Is the association between cigarette smoking and breast cancer modified by genotype? A review of epidemiologic studies and meta-analysis. Cancer Epidemiol Biomarkers Prev 2006;15:602-11.
50. King RS, Teitel CH, Kadlubar FF. In vitro bioactivation of N-hydroxy-2-amino-alpha-carboline. Carcinogenesis 2000;21:1347-54.
51. Ambrosone CB. Impact of genetics on the relationship between smoking and breast cancer risk. J Women's Cancer 2001;3:17-22.
52. Firozi PF, Bondy ML, Sahin AA, et al. Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer. Carcinogenesis 2002;23:301-6.
53. Sinha R, Gustafson DR, Kulldorff M, et al. 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine, a carcinogen in high-temperature-cooked meat, and breast cancer risk. J Natl Cancer Inst 2000;92:1352-4.
54. Zhu J, Chang P, Bondy ML, et al. Detection of 2-amino-1-methyl-6- phenylimidazo[4,5-b]-pyridine-DNA adducts in normal breast tissues and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2003;12:830-7.
55. Murtaugh MA, Sweeney C, Ma KN, et al. The CYP1A1 genotype may alter the association of meat consumption patterns and preparation with the risk of colorectal cancer in men and women. J Nutr 2005;135:179-86.